Absorbable hemostatic hydrogels comprising composites of sacrificial templates and honeycomb-like nanofibrous mats of chitosan.


Journal

Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555

Informations de publication

Date de publication:
24 05 2019
Historique:
received: 21 01 2019
accepted: 01 05 2019
entrez: 26 5 2019
pubmed: 28 5 2019
medline: 7 6 2019
Statut: epublish

Résumé

The development of hemostatic technologies that suit a diverse range of emergency scenarios is a critical initiative, and there is an increasing interest in the development of absorbable dressings that can be left in the injury site and degrade to reduce the duration of interventional procedures. In the current study, β-cyclodextrin polyester (CDPE) hydrogels serve as sacrificial macroporous carriers, capable of degradation under physiological conditions. The CDPE template enables the assembly of imprinted chitosan honeycomb-like monolithic mats, containing highly entangled nanofibers with diameters of 9.2 ± 3.7 nm, thereby achieving an increase in the surface area of chitosan to improve hemostatic efficiency. In vivo, chitosan-loaded cyclodextrin (CDPE-Cs) hydrogels yield significantly lower amounts of blood loss and shorter times to hemostasis compared with commercially available absorbable hemostatic dressings, and are highly biocompatible. The designed hydrogels demonstrate promising hemostatic efficiency, as a physiologically-benign approach to mitigating blood loss in tissue-injury scenarios.

Identifiants

pubmed: 31127114
doi: 10.1038/s41467-019-10290-1
pii: 10.1038/s41467-019-10290-1
pmc: PMC6534699
doi:

Substances chimiques

Biocompatible Materials 0
Cyclodextrins 0
Hemostatics 0
Hydrogels 0
Chitosan 9012-76-4

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2307

Subventions

Organisme : National Aeronautics and Space Administration (NASA)
ID : NNX15AQ08H
Pays : International
Organisme : Welch Foundation
ID : A-0001
Pays : International

Références

Biotechnol Adv. 2010 Jan-Feb;28(1):142-50
pubmed: 19913083
Biomacromolecules. 2008 Feb;9(2):640-50
pubmed: 18186608
Biotechnol Adv. 2011 May-Jun;29(3):322-37
pubmed: 21262336
Biomaterials. 2005 Sep;26(27):5427-32
pubmed: 15860199
Biomacromolecules. 2007 Feb;8(2):594-601
pubmed: 17291083
Biomaterials. 1997 Apr;18(7):567-75
pubmed: 9105597
ACS Biomater Sci Eng. 2017 Dec 11;3(12):3675-3686
pubmed: 33445402
Med Devices (Auckl). 2017 Nov 30;10:273-279
pubmed: 29238233
Adv Colloid Interface Sci. 2014 May;207:216-22
pubmed: 24556234
J Pharm Biomed Anal. 2003 Aug 21;32(6):1149-58
pubmed: 12907258
MMWR Morb Mortal Wkly Rep. 2015 Oct 02;64(38):1078-82
pubmed: 26421663
Adv Mater. 2018 May 29;:e1801100
pubmed: 29845657
Mil Med. 2016 Aug;181(8):907-12
pubmed: 27483532
Eur J Pharm Biopharm. 2004 Jan;57(1):19-34
pubmed: 14729078
J Trauma. 2008 Oct;65(4):884-90; discussion 890-2
pubmed: 18849807
ACS Nano. 2018 Oct 23;12(10):10493-10500
pubmed: 30256608
J Trauma. 2006 Mar;60(3):655-8
pubmed: 16531872
J Vet Sci. 2015;16(4):517-23
pubmed: 26119165
Adv Mater. 2018 Jan;30(4):
pubmed: 29164804
Mater Sci Eng C Mater Biol Appl. 2018 Apr 1;85:27-36
pubmed: 29407154
Biomaterials. 2000 Nov;21(21):2155-61
pubmed: 10985488
Mil Med. 2014 May;179(5):497-514
pubmed: 24806495
J Invest Surg. 2013 Jun;26(3):141-8
pubmed: 23514063
Int J Biol Macromol. 2015 Apr;75:322-9
pubmed: 25661881
Biomaterials. 2011 Oct;32(28):6655-62
pubmed: 21676458
J Surg Res. 2010 Nov;164(1):e125-9
pubmed: 20863522
J Spec Oper Med. 2015 Summer;15(2):48-53
pubmed: 26125164
J Emerg Med. 2009 Jul;37(1):1-7
pubmed: 18024069
J Biomed Mater Res. 2002 Jul;61(1):1-8
pubmed: 12001239
Proc (Bayl Univ Med Cent). 2013 Apr;26(2):120-3
pubmed: 23543966
J Biomater Appl. 2017 Mar;31(8):1099-1107
pubmed: 28077050
Colloids Surf B Biointerfaces. 2018 Jun 1;166:127-134
pubmed: 29558703
Mar Drugs. 2018 Aug 04;16(8):
pubmed: 30081571
Adv Mater. 2015 May 20;27(19):2989-95
pubmed: 25833165

Auteurs

Eric E Leonhardt (EE)

Departments of Chemistry, Chemical Engineering, Materials Science & Engineering, and The Laboratory for Synthetic-Biologic Interactions, Texas A&M University, College Station, TX, 77842-3012, USA.

Nari Kang (N)

Departments of Chemistry, Chemical Engineering, Materials Science & Engineering, and The Laboratory for Synthetic-Biologic Interactions, Texas A&M University, College Station, TX, 77842-3012, USA.

Mostafa A Hamad (MA)

Department of Surgery, Faculty of Medicine, Assiut University, Assiut, 71515, Egypt.

Karen L Wooley (KL)

Departments of Chemistry, Chemical Engineering, Materials Science & Engineering, and The Laboratory for Synthetic-Biologic Interactions, Texas A&M University, College Station, TX, 77842-3012, USA. wooley@chem.tamu.edu.

Mahmoud Elsabahy (M)

Departments of Chemistry, Chemical Engineering, Materials Science & Engineering, and The Laboratory for Synthetic-Biologic Interactions, Texas A&M University, College Station, TX, 77842-3012, USA. mahmoud.elsabahy@chem.tamu.edu.
Department of Pharmaceutics and Assiut International Center of Nanomedicine, Al-Rajhy Liver Hospital, Assiut University, Assiut, 71515, Egypt. mahmoud.elsabahy@chem.tamu.edu.
Misr University for Science and Technology, 6th of October City, 12566, Egypt. mahmoud.elsabahy@chem.tamu.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH